Congress Asset Management Co. Has $66.04 Million Holdings in Integer Holdings Co. (NYSE:ITGR)

Congress Asset Management Co. raised its stake in Integer Holdings Co. (NYSE:ITGR) by 2.0% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 498,350 shares of the medical equipment provider’s stock after buying an additional 9,565 shares during the quarter. Congress Asset Management Co. owned 1.49% of Integer worth $66,041,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. Mather Group LLC. grew its holdings in shares of Integer by 304.3% in the 4th quarter. Mather Group LLC. now owns 190 shares of the medical equipment provider’s stock valued at $25,000 after buying an additional 143 shares during the period. Huntington National Bank grew its stake in Integer by 8,933.3% in the third quarter. Huntington National Bank now owns 271 shares of the medical equipment provider’s stock valued at $35,000 after acquiring an additional 268 shares during the period. R Squared Ltd bought a new stake in shares of Integer in the fourth quarter worth about $44,000. Versant Capital Management Inc raised its position in shares of Integer by 98.4% during the fourth quarter. Versant Capital Management Inc now owns 369 shares of the medical equipment provider’s stock worth $49,000 after purchasing an additional 183 shares during the period. Finally, Contravisory Investment Management Inc. lifted its holdings in shares of Integer by 210.8% during the 4th quarter. Contravisory Investment Management Inc. now owns 693 shares of the medical equipment provider’s stock valued at $92,000 after purchasing an additional 470 shares in the last quarter. Institutional investors own 99.29% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts have commented on the stock. Citigroup raised their target price on shares of Integer from $130.00 to $145.00 and gave the stock a “neutral” rating in a report on Wednesday, December 11th. Piper Sandler restated an “overweight” rating and set a $140.00 price objective (up from $125.00) on shares of Integer in a report on Friday, October 25th. Benchmark upped their target price on shares of Integer from $130.00 to $140.00 and gave the stock a “buy” rating in a research note on Monday, October 21st. KeyCorp lifted their price target on Integer from $144.00 to $154.00 and gave the company an “overweight” rating in a research note on Friday, January 24th. Finally, Wells Fargo & Company reaffirmed an “overweight” rating and set a $160.00 price objective on shares of Integer in a research report on Tuesday, December 3rd. One research analyst has rated the stock with a hold rating and eight have assigned a buy rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $146.56.

Integer Price Performance

NYSE:ITGR opened at $140.94 on Friday. The stock’s 50-day simple moving average is $137.84 and its 200 day simple moving average is $131.73. Integer Holdings Co. has a 52-week low of $94.56 and a 52-week high of $146.36. The company has a debt-to-equity ratio of 0.67, a quick ratio of 2.09 and a current ratio of 3.28. The company has a market cap of $4.73 billion, a P/E ratio of 43.50, a P/E/G ratio of 1.79 and a beta of 1.13.

Integer Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.